{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T09:10:48Z","timestamp":1759482648539},"reference-count":53,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Rheumatology"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1016\/j.berh.2003.09.002","type":"journal-article","created":{"date-parts":[[2004,3,4]],"date-time":"2004-03-04T10:24:58Z","timestamp":1078395898000},"page":"929-944","source":"Crossref","is-referenced-by-count":11,"title":["Musculoskeletal disorders in secondary amyloidosis and hereditary fevers"],"prefix":"10.1016","volume":"17","author":[{"given":"Gilles","family":"Grateau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2003.09.002_BIB1","doi-asserted-by":"crossref","unstructured":"Husby G (ed.) Reactive amyloidosis and the acute phase response. Bailli\u00e8re's Clinical Rheumatology 1994;8(3).","DOI":"10.1016\/S0950-3579(05)80112-8"},{"key":"10.1016\/j.berh.2003.09.002_BIB2","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/ard.59.8.577","article-title":"Where has secondary amyloid gone?","volume":"59","author":"Hazenberg","year":"2000","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2003.09.002_BIB3","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0950-3579(05)80119-0","article-title":"The epidemiology of AL and AA amyloidosis","volume":"8","author":"Simms","year":"1994","journal-title":"Bailli\u00e8re's Clinical Rheumatology"},{"key":"10.1016\/j.berh.2003.09.002_BIB4","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/0002-9343(68)90095-8","article-title":"A clinical analysis of the course and prognosis of forty-two patients with amyloidosis","volume":"44","author":"Brandt","year":"1968","journal-title":"American Journal of Medicine"},{"key":"10.1016\/j.berh.2003.09.002_BIB5","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/00005792-199107000-00002","article-title":"Secondary systemic amyloidosis: response and survival in 64 patients","volume":"70","author":"Gertz","year":"1991","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.berh.2003.09.002_BIB6","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/qjmed\/93.8.535","article-title":"Presentation, survival and prognostic markers in AA amyloidosis","volume":"93","author":"Joss","year":"2000","journal-title":"Quaterly Journal of Medicine"},{"key":"10.1016\/j.berh.2003.09.002_BIB7","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1093\/ndt\/17.11.2003","article-title":"A retrospective analysis for aetiology and clinical findings of 287 secondary amyloidosis cases in Turkey","volume":"17","author":"Tuglular","year":"2002","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1016\/j.berh.2003.09.002_BIB8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/qjmed\/95.4.211","article-title":"Unicentric Castleman's disease complicated by systemic AA amyloidosis: a curable disease","volume":"95","author":"Lachmann","year":"2002","journal-title":"Quaterly Journal of Medicine"},{"key":"10.1016\/j.berh.2003.09.002_BIB9","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/rheumatology\/38.6.499","article-title":"Amyloidosis in a nationwide series of 1666 subjects with rheumatoid arthritis who died during 1989 in Finland","volume":"38","author":"Myllykangas-Luosujarvi","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.berh.2003.09.002_BIB10","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/1529-0131(200101)44:1<66::AID-ANR10>3.0.CO;2-H","article-title":"The clinical significance of amyloid fat deposits in rheumatoid arthritis: a systematic long-term followup study using abdominal fat aspiration","volume":"44","author":"Gomez-Casanovas","year":"2001","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2003.09.002_BIB11","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00041552-200211000-00013","article-title":"Serum amyloid P component scintigraphy for diagnosis and monitoring amyloidosis","volume":"11","author":"Hawkins","year":"2002","journal-title":"Current Opinion in Nephrology and Hypertension"},{"key":"10.1016\/j.berh.2003.09.002_BIB12","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/ndt\/18.3.532","article-title":"Familial ATTR amyloidosis: microalbuminuria as a predictor of symptomatic disease and clinical nephropathy","volume":"18","author":"Lobato","year":"2003","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1016\/j.berh.2003.09.002_BIB13","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/ard.58.2.96","article-title":"A quantitative method for detecting deposits of amyloid A protein in aspirated fat tissue of patients with arthritis","volume":"58","author":"Hazenberg","year":"1999","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2003.09.002_BIB14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00428-001-0582-9","article-title":"Pathology, diagnosis and pathogenesis of AA amyloidosis","volume":"440","author":"Rocken","year":"2002","journal-title":"Virchows Archiv"},{"key":"10.1016\/j.berh.2003.09.002_BIB15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0140-6736(00)05252-1","article-title":"Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein","volume":"358","author":"Gillmore","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.berh.2003.09.002_BIB16","first-page":"898","article-title":"Chlorambucil in severe juvenile chronic arthritis: longterm followup with special reference to amyloidosis","volume":"26","author":"Savolainen","year":"1999","journal-title":"Journal of Rheumatology"},{"key":"10.1016\/j.berh.2003.09.002_BIB17","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1080\/030097400750041370","article-title":"Intensive treatment of rheumatoid arthritis reduces need for dialysis due to secondary amyloidosis","volume":"29","author":"Kaipiainen-Seppanen","year":"2000","journal-title":"Scandinavian Journal of Rheumatology"},{"key":"10.1016\/j.berh.2003.09.002_BIB18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF02200997","article-title":"Cytotoxic drug treatment of reactive amyloidosis in rheumatoid arthritis with special reference to renal insufficiency","volume":"6","author":"Ahlmen","year":"1987","journal-title":"Clinical Rheumatology"},{"key":"10.1016\/j.berh.2003.09.002_BIB19","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/rheumatology\/40.7.821","article-title":"Renal type AA amyloidosis associated with rheumatoid arthritis: a cohort study showing improved survival on treatment with pulse cyclophosphamide","volume":"40","author":"Chevrel","year":"2001","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2003.09.002_BIB20","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/rheumatology\/keg101","article-title":"Cytostatic therapy for AA amyloidosis complicating psoriatic spondyloarthropathy","volume":"42","author":"Mpofu","year":"2003","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2003.09.002_BIB21","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1002\/art.10581","article-title":"Rapid and complete resolution of proteinuria due to renal amyloidosis in a patient with rheumatoid arthritis treated with infliximab","volume":"46","author":"Elkayam","year":"2002","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2003.09.002_BIB22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm0295-143","article-title":"Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease","volume":"1","author":"Kisilevsky","year":"1995","journal-title":"Nature Medicine"},{"key":"10.1016\/j.berh.2003.09.002_BIB23","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/417254a","article-title":"Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis","volume":"417","author":"Pepys","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.berh.2003.09.002_BIB24","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/sj.ejhg.5200900","article-title":"The significance of paired MEFV mutations in individuals without symptoms of familial Mediterranean fever","volume":"10","author":"Tunca","year":"2002","journal-title":"European Journal of Human Genetics"},{"key":"10.1016\/j.berh.2003.09.002_BIB25","first-page":"S63","article-title":"Familial Mediterranean fever (FMF)-associated amyloidosis in childhood. Clinical features, course and outcome","volume":"19(5 supplement 24)","author":"Cakar","year":"2001","journal-title":"Clinical and Experimental Rheumatology"},{"key":"10.1016\/j.berh.2003.09.002_BIB26","first-page":"1136","article-title":"Identification of MEFV-independent modifying genetic factors for familial Mediterranean fever","volume":"67","author":"Cazeneuve","year":"2000","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/j.berh.2003.09.002_BIB27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00002281-200001000-00010","article-title":"The relation between familial Mediterranean fever and amyloidosis","volume":"12","author":"Grateau","year":"2000","journal-title":"Current Opininion in Rheumatology"},{"key":"10.1016\/j.berh.2003.09.002_BIB28","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(99)00990-3","article-title":"Acute phase response and evolution of familial Mediterranean fever","volume":"353","author":"Tunca","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.berh.2003.09.002_BIB29","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1002\/art.11102","article-title":"Familial Mediterranean fever among patients from Karabakh and the diagnosis value of MEFV gene analysis in all classically affected populations","volume":"48","author":"Cazeneuve","year":"2003","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2003.09.002_BIB30","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM198604173141601","article-title":"Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever","volume":"314","author":"Zemer","year":"1986","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.berh.2003.09.002_BIB31","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0301-2115(02)00417-7","article-title":"Familial Mediterranean fever and its implications for fertility and pregnancy","volume":"108","author":"Mijatovic","year":"2003","journal-title":"European Journal of Obstetrics Gynecology and Reproductive Biology"},{"key":"10.1016\/j.berh.2003.09.002_BIB32","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/rheumatology\/36.9.1005","article-title":"The efficacy of interferon alpha on colchicine-resistant familial Mediterranean fever attacks: a pilot study","volume":"36","author":"Tunca","year":"1997","journal-title":"British Journal of Rheumatology"},{"key":"10.1016\/j.berh.2003.09.002_BIB33","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0092-8674(00)80721-7","article-title":"Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes","volume":"97","author":"McDermott","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.berh.2003.09.002_BIB34","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1086\/321976","article-title":"The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers","volume":"69","author":"Aksentijevich","year":"2001","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/j.berh.2003.09.002_BIB35","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1002\/art.10429","article-title":"The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome","volume":"46","author":"Dode","year":"2002","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2003.09.002_BIB36","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00005792-200209000-00002","article-title":"The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder","volume":"81","author":"Hull","year":"2002","journal-title":"Medicine"},{"key":"10.1016\/j.berh.2003.09.002_BIB37","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1001\/archderm.136.12.1487","article-title":"Tumor necrosis factor receptor-associated periodic syndrome: a novel syndrome with cutaneous manifestations","volume":"136","author":"Toro","year":"2000","journal-title":"Archives of Dermatology"},{"key":"10.1016\/j.berh.2003.09.002_BIB38","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1002\/art.10448","article-title":"Monocytic fasciitis: a newly recognized clinical feature of tumor necrosis factor receptor dysfunction","volume":"46","author":"Hull","year":"2002","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2003.09.002_BIB39","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/rheumatology\/keg070","article-title":"Prospective study of anti-tumour necrosis factor receptor superfamily 1B fusion protein, and case study of anti-tumour necrosis factor receptor superfamily 1A fusion protein, in tumour necrosis factor receptor associated periodic syndrome (TRAPS): clinical and laboratory findings in a series of seven patients","volume":"42","author":"Drewe","year":"2003","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2003.09.002_BIB40","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0002-9343(00)00716-6","article-title":"Familial periodic fever and amyloidosis due to a new mutation in the TNFRSF1A gene","volume":"110","author":"Simon","year":"2001","journal-title":"American Journal of Medicine"},{"key":"10.1016\/j.berh.2003.09.002_BIB41","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1056\/NEJM200010053431412","article-title":"Treatment of the nephrotic syndrome with etanercept in patients with the tumor necrosis factor receptor-associated periodic syndrome","volume":"343","author":"Drewe","year":"2000","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.berh.2003.09.002_BIB42","first-page":"235","article-title":"Urticaria, deafness, and amyloidosis: a new heredo-familial syndrome","volume":"31","author":"Muckle","year":"1962","journal-title":"Quarterly Journal of Medecine"},{"key":"10.1016\/j.berh.2003.09.002_BIB43","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/03009748709102523","article-title":"A chronic, infantile, neurological, cutaneous and articular (CINCA) syndrome. A specific entity analysed in 30 patients","volume":"66","author":"Prieur","year":"1987","journal-title":"Scandinavian Journal of Rheumatology"},{"key":"10.1016\/j.berh.2003.09.002_BIB44","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000068883","article-title":"Muckle\u2013Wells syndrome and chronic infantile neurological cutaneous and articular (CINCA) syndrome: an overlap case with nosological discussion","volume":"206","author":"Granel","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.berh.2003.09.002_BIB45","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/ng756","article-title":"Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle\u2013Wells syndrome","volume":"29","author":"Hoffman","year":"2001","journal-title":"Nature Genetics"},{"key":"10.1016\/j.berh.2003.09.002_BIB46","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1086\/340786","article-title":"New mutations of CIAS1 that are responsible for Muckle\u2013Wells syndrome and familial cold urticaria: a novel mutation underlies both syndromes","volume":"70","author":"Dode","year":"2002","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/j.berh.2003.09.002_BIB47","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1086\/341357","article-title":"Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes","volume":"71","author":"Feldmann","year":"2002","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/j.berh.2003.09.002_BIB48","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0140-6736(84)92505-4","article-title":"Hyperimmunoglobulinaemia D and periodic fever: a new syndrome","volume":"i","author":"van der Meer","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.berh.2003.09.002_BIB49","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00005792-199405000-00002","article-title":"Hyperimmunoglobulinemia D and periodic fever syndrome. The clinical spectrum in a series of 50 patients. International Hyper-IgD Study Group","volume":"73","author":"Drenth","year":"1994","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.berh.2003.09.002_BIB50","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/9691","article-title":"Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome","volume":"22","author":"Houten","year":"1999","journal-title":"Nature Genetics"},{"key":"10.1016\/j.berh.2003.09.002_BIB51","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/9696","article-title":"Mutations in the gene encoding mevalonatekinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group","volume":"22","author":"Drenth","year":"1999","journal-title":"Nature Genetics"},{"key":"10.1016\/j.berh.2003.09.002_BIB52","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/sj.ejhg.5200725","article-title":"Familial Mediterranean Fever: association of elevated IgD plasma levels with specific MEFV mutations","volume":"9","author":"Medlej-Hashim","year":"2001","journal-title":"European Journal of Human Genetics"},{"key":"10.1016\/j.berh.2003.09.002_BIB53","first-page":"1221","article-title":"Limited efficacy of thalidomide in the treatment of febrile attacks of the hyper-IgD and periodic fever syndrome: a randomized, double-blind, placebo-controlled trial","volume":"298","author":"Drenth","year":"2001","journal-title":"Journal of Pharmacology and Experimental Therapeutics"}],"container-title":["Best Practice &amp; Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694203001104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694203001104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T16:26:31Z","timestamp":1705076791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694203001104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["S1521694203001104"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2003.09.002","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}